Recognition in the 2018 Queen's Birthday Honours for one of the most influential figures in the history of Australia's pharmaceutical industry.
Retired MSD executive David Anstice has become an Officer (AO) in the General Division of the Order of Australia.
According to the citation, Mr Anstice has been recognised, "For distinguished service to Australia-America business relations, particularly in the pharmaceutical field, through roles with multinational and educational organisations."
Mr Anstice was appointed managing director of MSD Australia at a young age before going on to lead its regional businesses in Europe, North America and Asia.
He played a role for MSD in securing the global development and commercialisation rights to the HPV vaccine, which ultimately became GARDASIL, and was a leading figure in supporting the Australian expatriate community in the US.
Mr Anstice is currently a non-executive director of CSL and chairman and president of the University of Sydney USA Foundation.